Stay updated on GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page's revision label updated from v3.5.3 to v3.5.4, reflecting a new software version. No study content appears to be affected by this change.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedThe Taiwan recruitment site label was changed from Taoyuan to Taoyuan City, Taiwan, 33308, clarifying the exact city designation for this location. This update improves the accuracy of the study's geographic information as presented in the record.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site update rather than any change to the study information.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision: v3.5.2 has been added. Revision: v3.5.0 has been removed.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision: v3.5.0 applied (updating from v3.4.3).SummaryDifference0.0%

- Check91 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. No other content changes are visible on the page.SummaryDifference0.0%

Stay in the know with updates to GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial page.